1. Home
  2. GVP vs TSBX Comparison

GVP vs TSBX Comparison

Compare GVP & TSBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GVP
  • TSBX
  • Stock Information
  • Founded
  • GVP 1994
  • TSBX 2015
  • Country
  • GVP United States
  • TSBX United States
  • Employees
  • GVP N/A
  • TSBX N/A
  • Industry
  • GVP Computer Software: Prepackaged Software
  • TSBX
  • Sector
  • GVP Technology
  • TSBX
  • Exchange
  • GVP Nasdaq
  • TSBX Nasdaq
  • Market Cap
  • GVP 14.2M
  • TSBX 11.8M
  • IPO Year
  • GVP 1995
  • TSBX 2023
  • Fundamental
  • Price
  • GVP $4.06
  • TSBX $0.45
  • Analyst Decision
  • GVP Strong Buy
  • TSBX Strong Buy
  • Analyst Count
  • GVP 1
  • TSBX 2
  • Target Price
  • GVP $13.00
  • TSBX $6.88
  • AVG Volume (30 Days)
  • GVP 45.3K
  • TSBX 145.4K
  • Earning Date
  • GVP 11-12-2024
  • TSBX 11-07-2024
  • Dividend Yield
  • GVP N/A
  • TSBX N/A
  • EPS Growth
  • GVP N/A
  • TSBX N/A
  • EPS
  • GVP N/A
  • TSBX N/A
  • Revenue
  • GVP $44,789,000.00
  • TSBX N/A
  • Revenue This Year
  • GVP $29.76
  • TSBX N/A
  • Revenue Next Year
  • GVP $10.48
  • TSBX N/A
  • P/E Ratio
  • GVP N/A
  • TSBX N/A
  • Revenue Growth
  • GVP N/A
  • TSBX N/A
  • 52 Week Low
  • GVP $1.21
  • TSBX $0.45
  • 52 Week High
  • GVP $5.38
  • TSBX $5.75
  • Technical
  • Relative Strength Index (RSI)
  • GVP 57.08
  • TSBX 16.75
  • Support Level
  • GVP $4.02
  • TSBX $0.58
  • Resistance Level
  • GVP $4.05
  • TSBX $0.70
  • Average True Range (ATR)
  • GVP 0.04
  • TSBX 0.05
  • MACD
  • GVP -0.01
  • TSBX 0.03
  • Stochastic Oscillator
  • GVP 75.13
  • TSBX 1.10

About GVP GSE Systems Inc.

GSE Systems Inc is a company engaged in providing engineering, staffing, and simulation software to clients in the power and process industries. It also provides interactive computer-based tutorials and simulation software for the refining, chemical, and petrochemical industries. It functions through two segments: The engineering segment and the Workforce Solutions segment. Its geographical segments include the United States, Europe, and Asia, out of which the majority of the revenue is generated from the United States.

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

Share on Social Networks: